Showing 1441-1450 of 1655 results for "".
- Proof of COVID-19 Vaccination and Face Coverings Will Not Be Required to Attend Vision Expo East, March 31-April 3, 2022https://modernod.com/news/proof-of-covid-19-vaccination-and-face-coverings-will-not-be-required-to-attend-vision-expo-east-march-31-april-3-2022/2480686/The Vision Council and RX, co-organizers of Vision Expo, share that, in accordance with New York State and New York City guidelines and the updated requirements of the Javits Center, proof of COVID-19 vaccination and face coverings will not be required to attend Vision Expo East, tak
- Rabb-Venable Excellence in Ophthalmology Program Abstract Submission Open Until March 31https://modernod.com/news/rabb-venable-excellence-in-ophthalmology-program-abstract-submission-open-until-march-31/2478981/Each year, the National Medical Association–Ophthalmology Section sponsors the Rabb-Venable Excellence in Ophthalmology Program, which is committed to increasing diversity in eye care to better reflect the U.S. population. The Rabb-Venable Program encourages and fosters interest in ophthal
- Vaccine Rollout On Track, Expect 300M Doses Through March: Fedshttps://modernod.com/news/vaccine-rollout-on-track-expect-300m-doses-through-march-feds/2478672/If the initial success of the Pfizer-BioNTech rollout continues, and emergency use authorization (EAU) is granted to Moderna and Johnson & Johnson vaccines in development, Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the United Stat
- First FDA-Approved Treatment for MacTel Performed; Dr. Wykoff Shares Experiencehttps://modernod.com/news/first-fda-approved-treatment-for-mactel-performed/2482928/Neurotech Pharmaceuticals announced the first commercial manufacturing, shipment, and surgical procedure for its encapsulated cell-based gene therapy Encelto (revakinagene taroretcel-lwey). Encelto was approved in March 2025 as the first and only FDA
- iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaginghttps://modernod.com/news/ihealthscreen-awarded-us-patent-on-glaucoma-detection-based-on-ai-and-color-fundus-imaging/2482232/iHealthScreen was awarded a full US patent by USPTO on March 26, 2024 for the iPredict glaucoma detection model. The iPredict is designed to provide a fully automated detection report for glaucoma, which can be implemented in the primary care settings for screening and detecti
- Lenz Therapeutics Completes Merger with Graphite Bio; Debuts on Nasdaqhttps://modernod.com/news/lenz-therapeutics-completes-merger-with-graphite-bio-to-debut-on-nasdaq/2482177/Lenz Therapeutics announced the completion of its previously announced merger with Graphite Bio. The new combined company will operate under the name Lenz Therapeutics and will commence trading on Nasdaq under the ticker symbol “LENZ” on March 22, 2024. &ldquo
- Congress Passes Partial Adjustment to Medicare Physician Paymenthttps://modernod.com/news/congress-passes-partial-adjustment-to-medicare-physician-payment/2482172/Congress passed a partial government funding bill on March 8 that included policies to address cuts to the
- Apellis Appoints Philip Ferrone, MD, as Chief Medical Retina Advisorhttps://modernod.com/news/apellis-appoints-philip-ferrone-md-as-chief-medical-retina-advisor/2482154/Apellis Pharmaceuticals announced that retina specialist Philip Ferrone, MD, will join the company as Chief Medical Retina Advisor, effective March 18. “Phil is globally renowned for his leadership in retina, including as a past president of the American Society of Reti
- Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual Meetinghttps://modernod.com/news/nicox-announces-presentation-of-data-on-ncx-470-at-the-2024-american-glaucoma-society-annual-meeting/2482143/Nicox SA provided details of poster presentations highlighting data on NCX 470 at the 2024 American Glaucoma Society (AGS) annual meeting, one of the key scientific events in vision research, which was held February 29-March 3, 2024, in Huntington Beach, California. Poster tit
- The Vision Council and RX Announce New Host City for Vision Expo East 2025 and Future Yearshttps://modernod.com/news/the-vision-council-and-rx-announce-new-host-city-for-vision-expo-east-2025-future-years/2481903/The Vision Council and RX, co-owners of Vision Expo, announced that Vision Expo East 2025 will take place in Orlando, Florida at the Orange County Convention Center (OCCC) February 19-22, 2025. Vision Expo East’s final show in New York will occur March 14-17, 2024. Vision Exp